Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 10 Schemes (6.26%)
Foreign Institutions
Held by 10 Foreign Institutions (2.33%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
Pharmaceuticals & Biotechnology
USD 609 Million ()
NA
0.00%
-1.17
-999,999.00%
12.74






